0001562180-22-004031.txt : 20220516
0001562180-22-004031.hdr.sgml : 20220516
20220516160828
ACCESSION NUMBER: 0001562180-22-004031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220512
FILED AS OF DATE: 20220516
DATE AS OF CHANGE: 20220516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burke Steven Keith
CENTRAL INDEX KEY: 0001619834
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 22928911
MAIL ADDRESS:
STREET 1: 82 WILLIS ROAD
CITY: SUDBURY
STATE: MA
ZIP: 01776
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-05-12
false
0001517022
Akebia Therapeutics, Inc.
AKBA
0001619834
Burke Steven Keith
C/O AKEBIA THERAPEUTICS, INC
245 FIRST STREET
CAMBRIDGE
MA
02142
false
true
false
false
SVP, Chief Medical Officer
Common Stock
2022-05-12
4
A
false
200000.00
0.00
A
417663.00
D
Stock Option (Right to buy)
0.41
2022-05-12
4
A
false
200000.00
0.00
A
2023-05-12
2032-05-12
Common Stock
200000.00
200000.00
D
The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The restricted stock units will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date.
The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date.
/s/ Carolyn Rucci, attorney-in-fact for Steven K. Burke
2022-05-16